Djuro Kosanovic

2.5k total citations
62 papers, 1.4k citations indexed

About

Djuro Kosanovic is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Djuro Kosanovic has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 18 papers in Molecular Biology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Djuro Kosanovic's work include Pulmonary Hypertension Research and Treatments (31 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Mast cells and histamine (9 papers). Djuro Kosanovic is often cited by papers focused on Pulmonary Hypertension Research and Treatments (31 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Mast cells and histamine (9 papers). Djuro Kosanovic collaborates with scholars based in Germany, Russia and United Kingdom. Djuro Kosanovic's co-authors include Ralph T. Schermuly, Norbert Weißmann, Hossein Ardeschir Ghofrani, Werner Seeger, Friedrich Grimminger, Bhola K. Dahal, Akylbek Sydykov, Małgorzata Wygrecka, Argen Mamazhakypov and Akpay Sarybaev and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, International Journal of Molecular Sciences and Hypertension.

In The Last Decade

Djuro Kosanovic

61 papers receiving 1.3k citations

Peers

Djuro Kosanovic
Aneta Gandjeva United States
Wen Tian United States
M Levame France
Aneta Gandjeva United States
Djuro Kosanovic
Citations per year, relative to Djuro Kosanovic Djuro Kosanovic (= 1×) peers Aneta Gandjeva

Countries citing papers authored by Djuro Kosanovic

Since Specialization
Citations

This map shows the geographic impact of Djuro Kosanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Djuro Kosanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Djuro Kosanovic more than expected).

Fields of papers citing papers by Djuro Kosanovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Djuro Kosanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Djuro Kosanovic. The network helps show where Djuro Kosanovic may publish in the future.

Co-authorship network of co-authors of Djuro Kosanovic

This figure shows the co-authorship network connecting the top 25 collaborators of Djuro Kosanovic. A scholar is included among the top collaborators of Djuro Kosanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Djuro Kosanovic. Djuro Kosanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yapei, Yuyang Tian, Aleksandar Petrovic, et al.. (2024). Cathepsin L Promotes Pulmonary Hypertension via BMPR2/GSDME-Mediated Pyroptosis. Hypertension. 81(12). 2430–2443. 8 indexed citations
2.
Budnevsky, A. V., et al.. (2024). Involvement of Mast Cells in the Pathology of COVID-19: Clinical and Laboratory Parallels. Cells. 13(8). 711–711. 3 indexed citations
3.
Karnati, Srikanth, et al.. (2023). Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally. Cells. 12(9). 1278–1278. 5 indexed citations
4.
Karnati, Srikanth, Gülcan Güntaş, R. Rajendran, et al.. (2022). Quantitative Lipidomic Analysis of Takotsubo Syndrome Patients' Serum. Frontiers in Cardiovascular Medicine. 9. 797154–797154. 5 indexed citations
5.
Kosanovic, Djuro, Andrey I. Yaroshetskiy, З. М. Мержоева, et al.. (2021). Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale. International Journal of Infectious Diseases. 104. 108–110. 8 indexed citations
6.
Авдеев, С. Н., Н. В. Трушенко, S. Yu. Chikina, et al.. (2021). Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome. Respiratory Medicine. 185. 106489–106489. 17 indexed citations
8.
Hadžić, Stefan, Cheng‐Yu Wu, С. Н. Авдеев, et al.. (2020). Lung epithelium damage in COPD – An unstoppable pathological event?. Cellular Signalling. 68. 109540–109540. 35 indexed citations
9.
Sydykov, Akylbek, Argen Mamazhakypov, Aleksandar Petrovic, et al.. (2018). Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers. Frontiers in Physiology. 9. 609–609. 50 indexed citations
10.
Kwapiszewska, Grażyna, Jochen Wilhelm, Leigh M. Marsh, et al.. (2018). Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis. European Respiratory Journal. 52(5). 1800564–1800564. 62 indexed citations
11.
Sibinska, Zaneta, Tian Xia, Martina Korfei, et al.. (2016). Amplified canonical transforming growth factor-β signallingviaheat shock protein 90 in pulmonary fibrosis. European Respiratory Journal. 49(2). 1501941–1501941. 66 indexed citations
12.
Zakrzewicz, Dariusz, Anna Zakrzewicz, Miroslava Didiášová, et al.. (2015). Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(12). 2678–2688. 21 indexed citations
13.
Kosanovic, Djuro, Himal Luitel, Bhola K. Dahal, et al.. (2015). Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis. European Respiratory Journal. 46(4). 1084–1094. 43 indexed citations
14.
Agha, Elie El, Djuro Kosanovic, Ralph T. Schermuly, & Savério Bellusci. (2015). Role of fibroblast growth factors in organ regeneration and repair. Seminars in Cell and Developmental Biology. 53. 76–84. 27 indexed citations
15.
Kosanovic, Djuro, Bhola K. Dahal, Michael Seimetz, et al.. (2014). Histological Characterization of Mast Cell Chymase in Patients with Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease. Pulmonary Circulation. 4(1). 128–136. 36 indexed citations
16.
Wygrecka, Małgorzata, Bhola K. Dahal, Djuro Kosanovic, et al.. (2013). Mast Cells and Fibroblasts Work in Concert to Aggravate Pulmonary Fibrosis. American Journal Of Pathology. 182(6). 2094–2108. 85 indexed citations
17.
Veit, Florian, Oleg Pak, Bakytbek Egemnazarov, et al.. (2013). Function of NADPH Oxidase 1 in Pulmonary Arterial Smooth Muscle Cells After Monocrotaline-Induced Pulmonary Vascular Remodeling. Antioxidants and Redox Signaling. 19(18). 2213–2231. 63 indexed citations
18.
Kosanovic, Djuro, Baktybek Kojonazarov, Himal Luitel, et al.. (2011). Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension. Respiratory Research. 12(1). 87–87. 17 indexed citations
19.
Dahal, Bhola K., Djuro Kosanovic, Rajkumar Savai, et al.. (2011). Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats. Respiratory Research. 12(1). 60–60. 69 indexed citations
20.
Dahal, Bhola K., Aleksandra Tretyn, Soni Savai Pullamsetti, et al.. (2009). Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 181(2). 158–167. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026